E Florence

Summary

Affiliation: Institute of Tropical Medicine
Country: Belgium

Publications

  1. ncbi Transcriptome analysis of monocyte-HIV interactions
    Rafael Van den Bergh
    Department of Molecular and Cellular Interactions, VIB, Brussels, Belgium
    Retrovirology 7:53. 2010
  2. ncbi Control of viral replication after cessation of HAART
    Ellen Van Gulck
    Virology Unit, Department of Microbiology, Institute of Tropical Medicine, Antwerp ITMA, Antwerp, Belgium
    AIDS Res Ther 8:6. 2011
  3. ncbi HIV-1 V3 envelope deep sequencing for clinical plasma specimens failing in phenotypic tropism assays
    Ina Vandenbroucke
    Tibotec Virco Virology BVBA, Mechelen, Belgium
    AIDS Res Ther 7:4. 2010
  4. ncbi Decrease of vitamin D concentration in patients with HIV infection on a non nucleoside reverse transcriptase inhibitor-containing regimen
    Anali Conesa-Botella
    Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium
    AIDS Res Ther 7:40. 2010
  5. ncbi Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study
    E Florence
    Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium
    HIV Med 4:255-62. 2003
  6. ncbi Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral treatment
    W Schrooten
    Institute of Tropical Medicine, Department of Clinical Sciences, Antwerp, Belgium
    AIDS 15:1019-23. 2001
  7. ncbi The role of non-viral load surrogate markers in HIV-positive patient monitoring during antiviral treatment
    E Florence
    Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium
    Int J STD AIDS 15:538-42. 2004
  8. ncbi Ritonavir/saquinavir plus one nucleoside reverse transcriptase inhibitor (NRTI) versus indinavir plus two NRTIs in protease inhibitor-naive HIV-1-infected adults (IRIS study)
    E Florence
    Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium
    Antivir Ther 6:255-62. 2001
  9. ncbi Antiretroviral treatments used among adults with HIV infection in Europe
    R Colebunders
    Institute of Tropical Medicine, Antwerpen, Belgium
    AIDS Care 13:5-14. 2001
  10. ncbi Five-year immunological outcome of highly active antiretroviral treatment in a clinical setting: results from a single HIV treatment centre
    W Schrooten
    Institute of Tropical Medicine, Department of Clinical Sciences, Nationalestraat 155, 2000 Antwerp, Belgium
    Int J STD AIDS 15:523-8. 2004

Collaborators

Detail Information

Publications22

  1. ncbi Transcriptome analysis of monocyte-HIV interactions
    Rafael Van den Bergh
    Department of Molecular and Cellular Interactions, VIB, Brussels, Belgium
    Retrovirology 7:53. 2010
    ..We therefore applied a parallel approach of genome-wide microarray analysis and focused gene expression profiling on monocytes from patients in different stages of HIV infection and/or ART to further characterise these dysfunctions...
  2. ncbi Control of viral replication after cessation of HAART
    Ellen Van Gulck
    Virology Unit, Department of Microbiology, Institute of Tropical Medicine, Antwerp ITMA, Antwerp, Belgium
    AIDS Res Ther 8:6. 2011
    ..We failed to identify any immune activation or genetic markers that could offer an explanation for this unusual "secondary controller" status. But their viruses are clearly less fit compared to viruses from rebounders...
  3. ncbi HIV-1 V3 envelope deep sequencing for clinical plasma specimens failing in phenotypic tropism assays
    Ina Vandenbroucke
    Tibotec Virco Virology BVBA, Mechelen, Belgium
    AIDS Res Ther 7:4. 2010
    ..While good concordance was observed between gp120 phenotyping and prediction of R5-tropic virus, the results suggest that accurate prediction of X4-tropic virus would require further algorithm development...
  4. ncbi Decrease of vitamin D concentration in patients with HIV infection on a non nucleoside reverse transcriptase inhibitor-containing regimen
    Anali Conesa-Botella
    Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium
    AIDS Res Ther 7:40. 2010
    ..We compared 25-hydroxyvitamin D plasma [25-(OH)D] concentration in paired samples before and after 12 months of HAART. 25-(OH)D levels are presented using two different cut-offs: <20 ng/ml and <30 ng/ml...
  5. ncbi Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study
    E Florence
    Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium
    HIV Med 4:255-62. 2003
    ..To describe the prevalence and risk factors of poor CD4 count rise despite a good virological response on highly active antiretroviral treatment (HAART)...
  6. ncbi Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral treatment
    W Schrooten
    Institute of Tropical Medicine, Department of Clinical Sciences, Antwerp, Belgium
    AIDS 15:1019-23. 2001
    ..CONCLUSION: SD appears to be a common side-effect of HAART regimens containing a PI. The potential association between SD and other side-effects of HAART, such as lipodystrophy syndrome and neuropathy, should be investigated further...
  7. ncbi The role of non-viral load surrogate markers in HIV-positive patient monitoring during antiviral treatment
    E Florence
    Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium
    Int J STD AIDS 15:538-42. 2004
    ..A combination of increases in both haemoglobin levels and TLC proved a reliable predictor of successful treatment outcome comparable to the increase in CD4 count, but its specificity and sensitivity were low...
  8. ncbi Ritonavir/saquinavir plus one nucleoside reverse transcriptase inhibitor (NRTI) versus indinavir plus two NRTIs in protease inhibitor-naive HIV-1-infected adults (IRIS study)
    E Florence
    Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium
    Antivir Ther 6:255-62. 2001
    ..The proportion of patients who achieved a plasma viral load below the level of detection of 400 copies/ml at week 48 was 43% (39/90) in the ritonavir/saquinavir arm and 63% (57/90) in the indinavir arm (P=0.005, I..
  9. ncbi Antiretroviral treatments used among adults with HIV infection in Europe
    R Colebunders
    Institute of Tropical Medicine, Antwerpen, Belgium
    AIDS Care 13:5-14. 2001
    ..Between 1996 and 1997, many persons with HIV infection in Europe received a suboptimal ARV treatment regimen. Use of ARVs should be improved for intravenous drug users, persons with lower educational level and lower income...
  10. ncbi Five-year immunological outcome of highly active antiretroviral treatment in a clinical setting: results from a single HIV treatment centre
    W Schrooten
    Institute of Tropical Medicine, Department of Clinical Sciences, Nationalestraat 155, 2000 Antwerp, Belgium
    Int J STD AIDS 15:523-8. 2004
    ..03). Overall, the recovery of CD4 cell count after five years of HAART is good, although therapy interruptions have an important negative impact...
  11. ncbi Prevalence and factors associated with sexual dysfunction among HIV-positive women in Europe
    E Florence
    Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium
    AIDS Care 16:550-7. 2004
    ..Sexual dysfunction in women with HIV infection is frequent and is mainly driven by psychological factors and by the HIV diagnosis...
  12. ncbi Self-reported signs of lipodystrophy by persons living with HIV infection
    C Dreezen
    Institute of Tropical Medicine, Antwerpen, Belgium
    Int J STD AIDS 13:393-8. 2002
    ..CONCLUSIONS: This study suggests that multiple factors are associated with the occurrence of lipodystrophy, including the prolonged use of protease inhibitors...
  13. ncbi The use of complementary and alternative medicine by persons with HIV infection in Europe
    R Colebunders
    Institute of Tropical Medicine, Department of Clinical Sciences, Nationalestraat 155, B 2000 Antwerp, Belgium
    Int J STD AIDS 14:672-4. 2003
    ..The study shows that despite the availability of highly active antiretroviral therapy many people with HIV infection still take complementary and alternative medicine...
  14. ncbi Multiple tuberculous brain abscesses in an HIV-infected patient successfully treated with HAART and antituberculous treatment
    E Bottieau
    Dept of Clinical Sciences, Institute of Tropical Medicine, Nationalestraat 155, B 2000 Antwerp, Belgium
    Infection 31:118-20. 2003
    ..We describe an HIV-infected patient presenting with multiple TBA who recovered completely with a combination of HAART and anti-tuberculous treatment...
  15. ncbi Development of multiple abscesses in an HIV/TB co-infected patient after initiation of antituberculous and highly active antiretroviral therapy
    E Bottieau
    Departement Klinische Wetenschappen, Instituut voor Tropische Geneeskunde, Nationalestraat 155, B 2000 Antwerpen, Belgie
    Acta Clin Belg 57:219-22. 2002
    ..She developed fever, large abscesses and pleural and peritoneal effusions. Systemic symptoms decreased during corticosteroid treatment, but abscesses only disappeared 8 months after the start of the anti-TB treatment...
  16. ncbi Hepatitis C virus infection in HIV-infected men who have sex with men: sustained rising incidence in Antwerp, Belgium, 2001-2009
    E Bottieau
    Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium
    Euro Surveill 15:19673. 2010
    ..Targeted awareness campaigns and routine screening are urgently needed to limit further HCV spread and its expected long-term consequences...
  17. ncbi Rheumatological complications associated with the use of indinavir and other protease inhibitors
    E Florence
    Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium
    Ann Rheum Dis 61:82-4. 2002
    ..A survey using an anonymous questionnaire of 878 people with HIV infection treated with antiretroviral drugs suggests that other protease inhibitors may also cause arthralgia...
  18. ncbi Highly active antiretroviral treatment in countries with very limited resources: do we have cheaper alternatives?
    R Colebunders
    Int J STD AIDS 14:1-5. 2003
  19. ncbi HIV and sexual dysfunction
    R Colebunders
    Int J STD AIDS 14:69. 2003
  20. ncbi Neuropsychiatric reaction induced by clarithromycin
    R Colebunders
    Sex Transm Infect 78:75-6. 2002
  21. ncbi Patients with HIV infection and fever: a diagnostic approach
    E Florence
    Departement Klinische Wetenschappen, Instituut voor Tropische Geneeskunde, Antwerpen, Belgi
    Acta Clin Belg 57:184-90. 2002
    ..Since the incidence of opportunistic infections has dramatically decreased with the use of highly active antiretroviral treatments, other causes of fever including immune restoration disease, neoplasm and drug-fever should be considered...
  22. ncbi Sexual dysfunction in HIV-positive men is multi-factorial: a study of prevalence and associated factors
    D Asboe
    Directorate of HIV GU Medicine, Chelsea and Westminster Hospital, London, UK
    AIDS Care 19:955-65. 2007
    ..No significant association was seen with specific classes of anti-retrovirals. Older age, and depression were the variables most consistently associated with both EDF and LSD...